AAAAAA
Results:
1-13
|
Results: 13
Authors:
LANOE JL
Citation: Jl. Lanoe, IMPACT OF THE NHS REFORMS ON ENGLISH HOSP ITAL PRODUCTIVITY, Revue d'epidemiologie et de sante publique, 46(1), 1998, pp. 68-69
Authors:
COSSEE M
MOUTOU C
BIANCALANA V
BOUIX JC
PLESSIS G
DELOBEL B
CROQUETTE MF
GILGENKRANTZ S
LAMBERT JC
MALPUECH G
STOLL C
LANOE JL
PECHEVIS M
MANDEL JL
Citation: M. Cossee et al., THE FRAGILE-X-SYNDROME IS STILL UNDERDIAG NOSED - EFFICACY OF MOLECULAR TESTING IN MENTALLY-RETARDED PROBANDS, Archives de pediatrie, 4(3), 1997, pp. 227-236
Authors:
PELLETIERFLEURY N
LANOE JL
FLEURY B
FARDEAU M
Citation: N. Pelletierfleury et al., COST-EFFECTIVENESS OF 2 TYPES OF STRUCTUR ES DELIVERING LONG-TERM OXYGEN-THERAPY AT HOME, Revue d'epidemiologie et de sante publique, 45(1), 1997, pp. 53-63
Authors:
PELLETIERFLEURY N
FARGEON V
LANOE JL
FARDEAU M
Citation: N. Pelletierfleury et al., TRANSACTION COSTS ECONOMICS AS A CONCEPTUAL-FRAMEWORK FOR THE ANALYSIS OF BARRIERS TO THE DIFFUSION OF TELEMEDICINE, Health policy, 42(1), 1997, pp. 1-14
Authors:
FRIJA G
LHOSTE JM
GRISONI J
AURENGO A
CARSIN M
COATRIEUX JL
DIPAOLA R
GARANCE P
JOFFRE F
LANOE JL
JANIAUD P
Citation: G. Frija et al., A NEW APPROACH TO THE CONTROL OF DISTRIBUTION OF MEDICAL IMAGING EQUIPMENT IN FRANCE, Academic radiology, 3, 1996, pp. 97-100
Authors:
LANOE JL
Citation: Jl. Lanoe, ECONOMIC-EVALUATION IN THE HEALTH-CARE - CONTRIBUTIONS AND LIMITS, Gastroenterologie clinique et biologique, 20(1), 1996, pp. 33-35
Authors:
PELLETIERFLEURY N
LANOE JL
FLEURY B
FARDEAU M
Citation: N. Pelletierfleury et al., THE COST OF TREATING COPD PATIENTS WITH LONG-TERM OXYGEN-THERAPY IN AFRENCH POPULATION, Chest, 110(2), 1996, pp. 411-416
Authors:
KERLEAU M
FLORI YA
NALPAS B
LANOE JL
BERTHELOT P
FARDEAUGAUTHIER M
Citation: M. Kerleau et al., COST-BENEFIT-ANALYSIS OF ANTI-HEPATITIS-B VACCINATION POLICY, MS. Medecine sciences, 11(10), 1995, pp. 1474-1477
Authors:
HIRTZLIN I
MANDEL JL
LANOE JL
FARDEAUGAUTIER M
Citation: I. Hirtzlin et al., COMPARATIVE COST-ANALYSIS OF CYTOGENETIC AND MOLECULAR METHODS TO IDENTIFY GENETIC CAUSES OF MENTAL-RETARDATION, Revue d'epidemiologie et de sante publique, 43(3), 1995, pp. 205-214
Authors:
KERLEAU M
FLORI YA
NALPAS B
LANOE JL
BERTHELOT P
FARDEAUGAUTIER M
Citation: M. Kerleau et al., COST-BENEFIT-ANALYSIS OF ANTI-HEPATITIS-B VIRUS VACCINATION POLICY, Revue d'epidemiologie et de sante publique, 43(1), 1995, pp. 48-60
Authors:
LANOE JL
Citation: Jl. Lanoe, ABOUT THE MEETING ETHICS AND PUBLIC-HEALT H RESEARCH, Revue d'epidemiologie et de sante publique, 42(2), 1994, pp. 101-101
Authors:
SELAM JL
HAARDT MJ
BERNE C
DORANGE C
LANOE JL
BETHOUX JP
SLAMA G
Citation: Jl. Selam et al., COST-BENEFITS OF INTENSIVE INSULIN THERAP Y WITH EXTERNAL OR IMPLANTABLE PUMPS VS SUBCUTANEOUS INJECTIONS, Diabete et metabolisme, 19(5BIS), 1993, pp. 506-509
Authors:
LANOE JL
FLAHAUT MA
LEGRAIN M
ABADIE ME
BARDELAY MG
BEGAUD MB
BLUM C
CAULIN MC
CHICOYE A
ESCHWEGE E
FAGNANI MF
FLAHAULT MA
GENESTE MB
GOLINELLI D
GRANDCOLAS MC
LANOE MJL
LEBRUN T
LEGRAIN MM
LEPEN MC
LEVY MM
MANGEOT MJP
POUCHAIN MD
SAGNIER MP
SOUETRE ME
VIDAILHET MP
WEISSELBERG MC
Citation: Jl. Lanoe et al., PHARMACOECONOMIC EVALUATION - GOOD CLINIC AL PRACTICES AND METHODOLOGY, Therapie, 48(4), 1993, pp. 303-306
Risultati:
1-13
|